ArticleNature neuroscience2018
Maladaptive cortical hyperactivity upon recovery from experimental autoimmune encephalomyelitis.
Erratum issuedAbstract read
In one paragraph
Article in Nature neuroscience, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 48 papers.
0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed
6.2field-weighted citation impact, top 3% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
48 citing papers in PubMed, 80 citations in OpenAlex.
- Genome-wide association analyses highlight the neuronal contribution to multiple sclerosis susceptibility.Nature genetics · 2026Article
- Immune-mediated excitotoxicity in brain disorders.Nature reviews. Immunology · 2026Review
- The presynaptic protein bassoon is a biofluid biomarker of synaptic pathology in multiple sclerosis.EBioMedicine · 2026Article
- Article
- Slow wave canonical activity deviation concept: Toward a slow wave-based EEG-fMRI reference map for health-associated network function.iScience · 2026Article
- Transcriptome analysis of the prefrontal cortex identifies inflammatory genes associated with cognitive impairment in a model of multiple sclerosis.Cell death discovery · 2026Article
- Review
- A Translational Neural Network Mechanism of Resilience: Top-Down Control and Plasticity of the Visual Cortex Relates to Resilient Outcome and Performance.Research (Washington, D.C.) · 2026Article
- Exercise facilitates post-stroke recovery through mitigation of neuronal hyperexcitability via interleukin-10 signaling.Nature communications · 2025Article
- The immunological perspective of major depressive disorder: unveiling the interactions between central and peripheral immune mechanisms.Journal of neuroinflammation · 2025Review
- Demyelination and Remyelination: General Principles.Advances in neurobiology · 2025Review
- Autoimmune inflammation triggers aberrant astrocytic calcium signaling to impair synaptic plasticity.Brain, behavior, and immunity · 2024Article
- The neuropathobiology of multiple sclerosis.Nature reviews. Neuroscience · 2024Review
- Instability of excitatory synapses in experimental autoimmune encephalomyelitis and the outcome for excitatory circuit inputs to individual cortical neurons.Brain, behavior, and immunity · 2024Article
- The NR4A2/VGF pathway fuels inflammation-induced neurodegeneration via promoting neuronal glycolysis.The Journal of clinical investigation · 2024Article
- The selfish network: how the brain preserves behavioral function through shifts in neuronal network state.Trends in neurosciences · 2024Review
- ViNe-Seg: deep-learning-assisted segmentation of visible neurons and subsequent analysis embedded in a graphical user interface.Bioinformatics (Oxford, England) · 2024Article
- Article
- Significance of an altered lncRNA landscape in schizophrenia and cognition: clues from a case-control association study.European archives of psychiatry and clinical neuroscience · 2023Article
- Repetitive and compulsive behavior after Early-Life-Pain associated with reduced long-chain sphingolipid species.Cell & bioscience · 2023Article
Corrections and comments
- Erratum issued
Authors and funding
18 authors at 2 institutions in 1 country.
Erik EllwardtDepartment of Neurology Focus Program Translational Neurosciences (FTN) and Immunotherapy (FZI), Rhine-Main Neuroscience Network (rmn²), University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.
Gautam PramanikDepartment of Neurology Focus Program Translational Neurosciences (FTN) and Immunotherapy (FZI), Rhine-Main Neuroscience Network (rmn²), University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.
Dirk LuchtmanDepartment of Neurology Focus Program Translational Neurosciences (FTN) and Immunotherapy (FZI), Rhine-Main Neuroscience Network (rmn²), University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.
Tanja NovkovicFocus Program Translational Neurosciences & Institute of Physiology, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.
Eduardo Rosales JubalFocus Program Translational Neurosciences & Institute of Pathophysiology, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.ORCID http://orcid.org/0000-0001-5002-3823
Johannes VogtFocus Program Translational Neurosciences & Institute for Microscopic Anatomy and Neurobiology, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.
Isabelle ArnouxFocus Program Translational Neurosciences & Institute of Pathophysiology, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.ORCID http://orcid.org/0000-0003-4530-9944
Christina Francisca VogelaarDepartment of Neurology Focus Program Translational Neurosciences (FTN) and Immunotherapy (FZI), Rhine-Main Neuroscience Network (rmn²), University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.
Shibajee MandalDepartment of Neurology Focus Program Translational Neurosciences (FTN) and Immunotherapy (FZI), Rhine-Main Neuroscience Network (rmn²), University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.
Melanie SchmalzDepartment of Neurology Focus Program Translational Neurosciences (FTN) and Immunotherapy (FZI), Rhine-Main Neuroscience Network (rmn²), University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.
Zeke BargerFocus Program Translational Neurosciences & Institute of Pathophysiology, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.
Inigo Ruiz de AzuaFocus Program Translational Neurosciences & Institute for Physiological Chemistry, Johannes Gutenberg University Mainz, Mainz, Germany.
Tanja KuhlmannInstitute for Neuropathology, University Hospital Münster, Münster, Germany.
Beat LutzFocus Program Translational Neurosciences & Institute for Physiological Chemistry, Johannes Gutenberg University Mainz, Mainz, Germany.
Thomas MittmannFocus Program Translational Neurosciences & Institute of Physiology, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.
Stefan BittnerDepartment of Neurology Focus Program Translational Neurosciences (FTN) and Immunotherapy (FZI), Rhine-Main Neuroscience Network (rmn²), University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.
Frauke ZippDepartment of Neurology Focus Program Translational Neurosciences (FTN) and Immunotherapy (FZI), Rhine-Main Neuroscience Network (rmn²), University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany. frauke.zipp@unimedizin-mainz.de.ORCID http://orcid.org/0000-0002-1231-1928
Albrecht StrohFocus Program Translational Neurosciences & Institute of Pathophysiology, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany. albrecht.stroh@unimedizin-mainz.de.ORCID http://orcid.org/0000-0001-9410-4086
Johannes Gutenberg University Mainz · DEUniversity Hospital Münster · DE
Funding
No grant is acknowledged in the PubMed record.
Abstract
Multiple sclerosis (MS) patients exhibit neuropsychological symptoms in early disease despite the immune attack occurring predominantly in white matter and spinal cord. It is unclear why neurodegeneration may start early in the disease and is prominent in later stages. We assessed cortical microcircuit activity by employing spiking-specific two-photon Ca
Indexed as
AnimalsAnti-Inflammatory Agents, Non-SteroidalCarbazolesCells, CulturedCerebral CortexCuprizoneDisease Models, AnimalEgtazic AcidEncephalomyelitis, Autoimmune, ExperimentalExcitatory Amino Acid AntagonistsFemaleFreund's AdjuvantHyperkinesisMembrane PotentialsMiceMice, Transgenic1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl esterAnti-Inflammatory Agents, Non-SteroidalCarbazolescarprofenCuprizoneEgtazic AcidExcitatory Amino Acid AntagonistsFG 9041Freund's AdjuvantMyelin Proteolipid Proteinmyelin proteolipid protein (139-151)Peptide FragmentsProto-Oncogene Proteins c-fosQuinoxalinesSodium Channel BlockersTetrodotoxin
Identifiers
What OpenQuestion holds
Textmetadata
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.